CLSA Upgrades Bio-Rad Labs (BIO) to Outperform
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $285.28 +1.84%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
CLSA upgraded Bio-Rad Labs (NYSE: BIO) from Underperform to Outperform with a price target of $124.00 (from $103.00).
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Shares of Bio-Rad Labs closed at $110.63 yesterday.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Shares of Bio-Rad Labs closed at $110.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Upgrades First Solar (FSLR) to Outperform
- JPMorgan Upgrades Roblox Corp. (RBLX) to Overweight
- Goldman Sachs Upgrades Legrand SA (LR:FP) (LGRDY) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
